Chondrosarcoma is the most common primary malignant bone tumor of the chest wall, accounting for 30% of all chest wall malignant tumors. It originates from the costochondral junction (cartilage-bone transition zone of the rib) or sternum. Typically occurs in the 3rd-5th decades with slight male predominance. These are slow-growing, low-to-intermediate grade tumors; however, high-grade (dedifferentiated) forms may follow an aggressive course. The characteristic imaging finding is ring-and-arc calcification — pathognomonic of chondroid matrix. CT shows an expansile, lobulated mass at the costochondral junction with chondroid matrix calcification. MRI demonstrates markedly hyperintense T2 signal (high water content of hyaline cartilage) and lobular enhancement pattern. Treatment is wide surgical resection (chemotherapy and radiotherapy are traditionally ineffective for conventional chondrosarcoma). 5-year survival is >90% for low-grade tumors and <30% for high-grade/dedifferentiated tumors.
Age Range
30-70
Peak Age
50
Gender
Male predominant
Prevalence
Uncommon
Chondrosarcoma originates from malignant transformation of cartilage cells (chondrocytes). Primary chondrosarcoma develops de novo, while secondary chondrosarcoma arises from malignant transformation of pre-existing enchondroma or osteochondroma. The predilection for costochondral junction reflects this region's active endochondral ossification area susceptibility to neoplastic transformation. The tumor produces hyaline cartilage matrix — this matrix's high water content explains T2 hyperintensity on MRI. Chondroid matrix calcification mimics the endochondral ossification process — cartilage lobules calcify from periphery to center, creating ring-and-arc pattern. In low-grade tumors, cells are well-differentiated with low mitotic activity — slow growth and low metastasis risk. In high-grade/dedifferentiated forms, a high-grade non-cartilaginous component (fibrosarcoma/UPS-like) develops within the tumor — aggressive growth and metastatic potential. Lobular growth pattern is characteristic — septa separate tumor lobules and enhancement begins from septa.
Ring-shaped and arc-shaped calcification pattern on CT formed by peripheral-to-central calcification of cartilage lobules — pathognomonic finding of chondroid matrix tumors (enchondroma, chondrosarcoma).
The pathognomonic ring-and-arc calcification pattern of chondrosarcoma is seen on CT. This pattern reflects calcification of cartilage lobules from periphery to center — ring-shaped calcifications at the outer edges and arc-shaped high-attenuation calcifications within lobules. Calcifications form the tumor matrix and appear as high-attenuation islands between low-attenuation cartilage tissue. The tumor typically presents as an expansile, lobulated mass at the costochondral junction. Cortical thinning (cortical remodeling, scalloping) and cortical destruction presence reflect malignancy grade.
Report Sentence
An expansile lobulated mass measuring ___ cm demonstrating ring-and-arc calcification pattern is seen at the costochondral junction of the ___ rib, consistent with chondroid matrix tumor (chondrosarcoma).
On T2-weighted images, chondrosarcoma shows markedly hyperintense signal — fluid-like bright signal approaching CSF intensity. This reflects the high water content of hyaline cartilage matrix. Lobular morphology is characteristic — tumor lobules are separated by low-signal septa. In low-grade tumors, homogeneous hyperintensity predominates; in high-grade/dedifferentiated tumors, heterogeneous signal (necrosis, hemorrhage, myxoid changes) may be seen. Calcified areas show low signal on all sequences (low proton density in calcium).
Report Sentence
The costochondral junction lesion shows markedly hyperintense signal and lobular morphology on T2-weighted images, consistent with chondroid matrix tumor.
On contrast-enhanced MRI, chondrosarcoma shows characteristic peripheral and septal enhancement pattern. Fibrovascular septa and peripheral margins of tumor lobules enhance, while the cartilage matrix of lobules does not enhance (avascular hyaline cartilage). This pattern reveals lobular tumor architecture. In low-grade tumors, thin septal enhancement is seen; in high-grade tumors, thick and irregular enhancement occurs. In tumors with dedifferentiated component, heterogeneous solid enhancement may be seen — this component is also not hyperintense on T2.
Report Sentence
On contrast-enhanced MRI, the lesion shows peripheral and septal enhancement pattern with non-enhancing cartilage lobules; lobular tumor architecture consistent with chondrosarcoma.
On CT, chondrosarcoma appears as an expansile, lobulated mass at the costochondral junction (anterior rib-cartilage transition zone). The rib is expanded — slow growth allows bone remodeling. Cortex may be thinned (scalloping) or partially disrupted; however, complete cortical destruction is rare in low-grade tumors. Soft tissue component may show extraosseous extension — pleural or chest wall soft tissue invasion. Periosteal reaction is usually not prominent (slow growth). Average size is 5-10 cm (at diagnosis).
Report Sentence
An expansile lobulated mass measuring ___ cm with cortical thinning and chondroid matrix calcification is seen at the costochondral junction of the ___ rib.
On PET-CT, FDG uptake of chondrosarcoma correlates with tumor grade. In low-grade (grade 1) chondrosarcomas, FDG uptake may be low-to-intermediate (SUVmax 2-4) — risk of false-negative results. In high-grade (grade 2-3) and dedifferentiated chondrosarcomas, markedly increased FDG uptake (SUVmax >5-8) is seen. In tumors with dedifferentiated component, a focal intense uptake area ('nodule within nodule') may indicate the dedifferentiation zone — critical for biopsy guidance. PET-CT is used for recurrence/residual disease and distant metastasis assessment.
Report Sentence
FDG uptake with SUVmax ___ is seen in the costochondral junction lesion on PET-CT, requiring correlation with tumor grade.
Criteria
Most common type (85%), producing hyaline cartilage matrix, graded 1-3
Distinct Features
Ring-and-arc calcification, marked T2 hyperintensity, lobular septal enhancement; low-grade forms slow, high-grade forms rapid growth
Criteria
Development of high-grade non-cartilaginous component (UPS/fibrosarcoma-like) within low-grade chondrosarcoma
Distinct Features
Bimorphic appearance: chondroid area (T2 bright, calcified) + dedifferentiated area (T2 intermediate, solid, enhancing); focal intense FDG uptake in dedifferentiated area on PET; poor prognosis (<30% 5-year survival)
Criteria
Rare aggressive variant, small round blue cell component + cartilage islands; young age (2nd-3rd decade), 30% extraosseous
Distinct Features
Heterogeneous enhancement, hypervascular, mixed T2 signal, solid tissue between calcified cartilage islands; high FDG uptake; late recurrence risk (even after 10+ years)
Distinguishing Feature
Enchondroma: benign, small (<5 cm), well-defined, no cortical destruction, scalloping <2/3 cortex; chondrosarcoma: large, cortical destruction, periosteal reaction, >5 cm, endosteal scalloping >2/3 cortex
Distinguishing Feature
Metastasis: no ring-and-arc calcification, known primary malignancy, moth-eaten/permeative destruction, multiple lesions; chondrosarcoma: ring-and-arc calcification, costochondral junction, solitary, expansile
Distinguishing Feature
Ewing sarcoma: pediatric/young, onion skin periosteal reaction, intermediate T2, aggressive destruction, no cartilage matrix; chondrosarcoma: adult, expansile, markedly hyperintense T2, ring-and-arc calcification
Distinguishing Feature
Osteosarcoma: osteoid matrix (amorphous dense calcification), sunburst periosteal reaction, Codman triangle, young age; chondrosarcoma: chondroid matrix (ring-and-arc), expansile, minimal periosteal reaction, adult
Urgency
urgentManagement
surgicalBiopsy
NeededFollow-up
6-monthPrimary treatment for chest wall chondrosarcoma is wide surgical resection (minimum 2-4 cm clean surgical margins). Conventional chondrosarcoma is resistant to chemotherapy and radiotherapy — surgery is the only curative option. Biopsy is required for definitive diagnosis and grading — CT or US-guided core biopsy is preferred; incisional biopsy should be coordinated with surgical plan. Neoadjuvant/adjuvant chemotherapy may be administered for dedifferentiated and mesenchymal chondrosarcomas. Chest wall reconstruction (mesh/bone graft/muscle flap) is needed for wide resections. Follow-up: 6-monthly CT for first 2 years, then annually for recurrence monitoring; late recurrence (10+ years) may occur — long-term follow-up recommended.
Wide surgical excision is the gold standard for chondrosarcoma treatment. Chemotherapy and radiotherapy are generally ineffective (low mitotic activity). Low-grade (Grade I) tumors have low local recurrence rates and excellent prognosis (>90% 5-year survival). High-grade (Grade III) tumors carry increased metastasis risk (lung, bone) and worse prognosis. Positive surgical margins are the most important prognostic factor.